Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of the American Chemical Society|November 14, 2007
Total synthesis of (-)-okilactomycinAmos B Smith, Kallol Basu, Todd BosanacJournal of the American Chemical Society|January 28, 2009
Evolution of the total synthesis of (-)-okilactomycin exploiting a tandem oxy-cope rearrangement/oxidation, a Petasis-Ferrier union/rearrangement, and ring-closing metathesisAmos B Smith, Todd Bosanac, Kallol BasuOrganic Letters|June 24, 2016
Solution to the C3-Arylation of Indazoles: Development of a Scalable MethodKallol Basu, Marc Poirier, Rebecca T RuckOrganic Letters|March 14, 2003
Relative rate profile for ring-closing metathesis of a series of 1-substituted 1,7-octadienes as promoted by a 4,5-dihydroimidazol-2-ylidene-coordinated ruthenium catalystXin Guo, Kallol Basu, Jose A Cabral, et al.Bioorganic & Medicinal Chemistry|July 29, 2017
Development of a stereoselective and scalable process for the preparation of a methylcyclobutanol-pyridyl etherJeffrey T Kuethe, Kallol Basu, Robert K Orr, et al.Bioorganic & Medicinal Chemistry Letters|January 10, 2012
Pyrazoloquinolines as PDE10A inhibitors: discovery of a tool compoundWilliam T McElroy, Zheng Tan, Kallol Basu, et al.The Journal of Pharmacology and Experimental Therapeutics|September 27, 2015
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase InhibitionMatthew J Fell, Christian Mirescu, Kallol Basu, et al.Journal of Medicinal Chemistry|March 22, 2017
Can We Make Small Molecules Lean? Optimization of a Highly Lipophilic TarO InhibitorMihirbaran Mandal, Zheng Tan, Christina Madsen-Duggan, et al.Journal of Medicinal Chemistry|March 1, 2017
Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase ActivityJack D Scott, Duane E DeMong, Thomas J Greshock, et al.Pageof 1